Recovery Time in Thai Patients With Upper or Lower Respiratory Tract Infections Treated With Klacid MR

NCT01076153 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 760

Last updated 2011-07-12

Study results available
· View outcomes & findings →

Summary

The investigators hypothesize that Klacid modified release (MR) shortens symptom recovery time in Thai patients with upper or lower respiratory tract infections.

Conditions

  • Respiratory Tract Infection

Interventions

DRUG

Clarithromycin (Klacid® MR)

Klacid MR 500mg (clarithromycin)

Sponsors & Collaborators

Principal Investigators

  • Savary Om, M.D. · Abbott

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2010-04-30
Completion
2010-04-30

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01076153 on ClinicalTrials.gov